India Glycols Limited
India Glycols Limited Fundamental Analysis
India Glycols Limited (INDIAGLYCO.BO) shows moderate financial fundamentals with a PE ratio of 21.54, profit margin of 6.59%, and ROE of 11.94%. The company generates $43.9B in annual revenue with strong year-over-year growth of 14.40%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 46.8/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze INDIAGLYCO.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakINDIAGLYCO.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateINDIAGLYCO.BO shows balanced valuation metrics.
Growth Score
ExcellentINDIAGLYCO.BO delivers strong and consistent growth momentum.
Financial Health Score
ModerateINDIAGLYCO.BO shows balanced financial health with some risks.
Profitability Score
WeakINDIAGLYCO.BO struggles to sustain strong margins.
Key Financial Metrics
Is INDIAGLYCO.BO Expensive or Cheap?
P/E Ratio
INDIAGLYCO.BO trades at 21.54 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, INDIAGLYCO.BO's PEG of 5.60 indicates potential overvaluation.
Price to Book
The market values India Glycols Limited at 2.43 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 6.33 times EBITDA. This is generally considered low.
How Well Does INDIAGLYCO.BO Make Money?
Net Profit Margin
For every $100 in sales, India Glycols Limited keeps $6.59 as profit after all expenses.
Operating Margin
Core operations generate 10.71 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.94 in profit for every $100 of shareholder equity.
ROA
India Glycols Limited generates $4.38 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
India Glycols Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
India Glycols Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
INDIAGLYCO.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
21.54
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
5.60
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.43
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.52
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.86
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.83
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.12
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
0.11
vs 25 benchmark
How INDIAGLYCO.BO Stacks Against Its Sector Peers
| Metric | INDIAGLYCO.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 21.54 | 27.18 | Better (Cheaper) |
| ROE | 11.94% | 860.00% | Weak |
| Net Margin | 6.59% | -121084.00% (disorted) | Weak |
| Debt/Equity | 0.86 | 0.41 | Weak (High Leverage) |
| Current Ratio | 0.83 | 4.81 | Weak Liquidity |
| ROA | 4.38% | -7173.00% (disorted) | Weak |
INDIAGLYCO.BO outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews India Glycols Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
10.19%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
101.39%
Industry Style: Cyclical, Commodity, Value
High GrowthFCF CAGR
5.49%
Industry Style: Cyclical, Commodity, Value
Growing